Veterinary oncology news
Newly opened treatment trials, meaningful recruitment changes and other developments that may matter to owners looking for cancer treatment options.
Missouri recruits cats for radiation followed by chemotherapy for GI lymphomaOctober 23, 2026. The study tests whole-abdomen radiation before chemotherapy for untreated large-cell intestinal lymphoma; radiation costs are covered.
CanCan launches a tumor sequencing panel for catsOctober 13, 2026. What the 75-gene tissue test examines, sample requirements, cost and the limits of its treatment suggestions.
Canos studies a blood test for monitoring canine cancerOctober 10, 2026. How the test looks for cancer-associated DNA patterns and how owners can apply for free testing.
K9-LiquiDX: looking for canine cancer signals in the bloodOctober 1, 2026. What CanCan’s blood test is offered for, early clinical experience, costs and ordering through your veterinarian.
ReachGlio opens in Madrid for dogs with high-grade gliomaSeptember 30, 2026. A new trial combines SNGR-TNF with temozolomide and tackles the same glioma problem from a different angle than current U.S. studies.
Texas A&M opens radiation trial for feline GI lymphomaSeptember 30, 2026. Whole-abdomen radiation is being studied for cats with small-cell GI lymphoma that has relapsed or not responded sufficiently to standard chemotherapy.
How Laverdia worksSeptember 29, 2026. An oral FDA-approved treatment for canine lymphoma that can be given at home, but should not be mistaken for an equivalent replacement for CHOP.
Penn Vet opens a CAR-T study for dogs with histiocytic sarcomaSeptember 29, 2026. The pilot requires measurable disease and STEAP1 screening; we compare its early evidence with the trametinib trial.
BARC is recruiting dogs and cats for cancer treatment trialsSeptember 27, 2026. Gold nanoparticle treatment includes selected dog and cat tumors; two other recruiting studies are for dogs.
Taiwan trial tests inhaled IL-15 for canine lung metastasesSeptember 25, 2026. A rare non-US study builds on mixed published evidence in dogs with melanoma or osteosarcoma.
Purdue adds experimental tumor ablation to standard cancer treatment in three trialsSeptember 20, 2026. Standard treatment remains in place and part of the care is study-funded; additional clinical benefit from HIFU or H-FIRE has not been established.
NC State bladder cancer immunotherapy trial closes enrollment September 30September 17, 2026. The fully funded eight-day IL-12 treatment study has no placebo group.
Wisconsin recruits dogs with peripheral T-cell lymphoma for 90Y-NM600 therapySeptember 17, 2026. All enrolled dogs receive targeted radiopharmaceutical therapy; most study costs are covered after screening.
Cornell opens Smart-Start trial for dogs with B-cell lymphomaSeptember 17, 2026. A biology-guided pre-treatment is followed by standard CHOP chemotherapy; there is no placebo.